Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-31 | New | $4,396,329 | $4,396,329 | Other | 06b | SEC link |
| 2024-11-14 | New | $9,428,594 | $9,428,594 | Other | 06b | SEC link |
| 2023-07-18 | New | $7,500,001 | $7,500,001 | Other | 06b | SEC link |
| 2022-12-08 | New | $250,000 | $250,000 | Debt Only | 06b | SEC link |
| 2022-07-25 | New | $150,000 | $150,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Jeff Cole | Executive |
| Jeffrey Cole | Executive |
| James J. Ferguson | Executive |
| Lee S. Golden | Director |
| Robert Lisicki | Director |
| Douglas W. Losordo | Executive |
| John R. Murphy | Director |
| Quang X. Pham | Director, Executive |
| Matthew K. Szot | Executive |
| Glynn Wilson | Director |
| Steven Zelenkofske | Director |